Bath & Body Works (BBWI) is a specialty home-fragrance and personal-care retailer executing a multi-year turnaround, while Copart (CPRT) is a global leader in online vehicle auctions and automotive remarketing. BBWI has delivered stronger relative price momentum over the past year, while CPRT has traded under pressure amid a leadership transition and softer U.S. insurance volume.
The central $39 target is the arithmetic mean of eight verified analyst price targets, rounded from a calculated average of $38.50. Shares recently traded around $31, so reaching $39 requires a gain of roughly 26% — a substantial move, not a trivial one.
Copart, Inc. (CPRT) reports first quarter fiscal 2027 results on December 1, 2026 , before the market opens. Wall Street expects earnings per share (EPS) of roughly $0.40 , slightly below the $0.41 reported a year ago.
Digital identity and AI-led innovation are emerging as the company's primary growth catalysts, with management describing identity-fraud mitigation as the leading conversation in nearly every new deal. Sterling acquisition synergies are tracking ahead of plan, with a raised target of $65–$80 million in total run-rate synergies by the end of 2026 supporting margin expansion.
The central target used here is $28 , about 30% above the latest close of roughly $21.53. The target is the arithmetic mean of verified individual analyst price targets (approximately $27.75), rounded to a reader-friendly level; the underlying range runs from $24 to $34.
First Advantage shares were trading near $21.24, up roughly 8% over the trailing 30 days, reflecting a recovery from the stock's late-September pullback. Third-quarter 2026 revenue rose 13.8% year over year to $465.8 million, exceeding consensus, while adjusted diluted EPS climbed 27% to $0.38.
BUUU fell -8.66% in Thursday's regular session, sliding from the prior close of $4.85 to $4.43, with the decline building through the morning rather than in premarket or after-hours trade. No verified news or fundamental catalyst found: no fresh filing, release or analyst action was published before the move, so the drop is likely profit-taking and thin, speculative trading in a micro-cap whose typical daily swing over the last 60 sessions was about 5.8%.
Primech Holdings (PMEC) dropped from a $0.4839 close on Nov 18 to $0.3919 on Nov 19, a -18.75% decline recorded during regular market hours. No verified news or fundamental catalyst found: no company release, SEC filing or analyst action dated Nov 19 explains the drop, which is likely profit-taking after gains of +21.7% and +15.2% in the two prior sessions (about +40% combined) against a 60-session average absolute move of roughly 6.2%.
MMS dropped -4.63% (-$3.02) to $62.24 from Wednesday's close of $65.26, with most of the decline coming in regular-session trading after the opening bell. The move followed fiscal fourth-quarter results released before the open: adjusted EPS of $2.11 missed the $2.31 consensus and revenue of $1.30B fell shy of $1.32B, while fiscal 2027 adjusted EPS guidance of $7.50-$8.00 landed below the $8.01 consensus.
UniFirst (UNF) fell -4.88%, or -$11.78, to $229.44 on Thursday morning from Wednesday's close of $241.22, gapping down at the open during regular-session trading. The drop followed an after-hours Semafor report that Cintas' chairman met with Trump to salvage the $5.5 billion takeover, with FTC Chair Ferguson inclined to challenge it and a lawsuit expected, reversing Wednesday's +6.58% rally built on conflicting clearance optimism.
SMX dropped -14.12% to $2.98 from the prior session close of $3.47, with the move taking place during regular Nasdaq market hours. No verified news or fundamental catalyst found. The decline is likely a continuation of the unwind in a post-reverse-split speculative spike: shares ran from $3.30 on Nov 4 to $19.25 on Nov 10 (+483%) before collapsing, and today's -14.12% is close to the stock's average absolute daily move of roughly 12% over the past 60 sessions.
System1 (SST) dropped -8.54% to $0.75 from the prior close of $0.82, with the decline occurring during Wednesday's regular session rather than in premarket or after-hours trading. The move extends the selloff set off on November 12, when third-quarter revenue fell -58% to $26.0 million, EPS came in at -$6.07, management flagged substantial going-concern doubt, and the company announced plans to voluntarily delist from the NYSE; no fresh company-specific news was published Wednesday.
BUUU fell from a $5.35 close on Nov 17 to $4.365, a -18.32% drop, during regular Nasdaq trading shortly before midday, extending a slide that began at the open. No verified news or fundamental catalyst found to explain the decline; the move looks consistent with profit-taking in an extended micro-cap, given the stock's +33% gain over the past month and a typical daily swing of +5.7%/ -5.7% across the last 60 sessions.
LICN dropped -32.27% to $0.0149 from Tuesday's close of $0.0220, with the selling taking place during regular Nasdaq trading hours. Lichen confirmed on Nov. 18 that its 1-for-100 reverse split takes effect at the Nov. 20 open, a compliance step that hit alongside persistent dilution from its $0.20-per-unit offering.
Dolby Laboratories reported fourth-quarter fiscal 2026 revenue of $373.5 million, up 21.7% year over year. Adjusted (non-GAAP) earnings per share (EPS) came in at $1.25, beating the consensus estimate of $1.19.
The central stock price target of $81 is the arithmetic mean of three verifiable analyst price targets ($74, $80, and $90), rounded from about $81.33. At a latest verified price near $61 , reaching $81 would require a gain of roughly 32% — a substantial move, not a marginal one.
LICN fell from a $0.0270 close to $0.02255, a move of -16.48%, during Tuesday's regular session, after opening at $0.0238 and sliding to a $0.022 low. No verified news or fundamental catalyst found for Tuesday; the decline is consistent with continuing dilution overhang from the Nov. 10 $3.5 million registered direct offering priced at $0.20 per unit, roughly 59% below the last pre-deal close, plus selling ahead of the Nov. 19 one-for-100 reverse split.
BUUU Group Limited slipped -0.91%, easing from Monday's $5.50 close to $5.45 in the opening minutes of the regular session on Tuesday, November 17. No verified news or fundamental catalyst found; the pullback is likely routine profit-taking after the stock's recent rebound (+7.91% on November 12, +3.38% on November 16) in a micro-cap that averages roughly ±5.7% daily swings.
The central $68 stock price target is the arithmetic mean of 12 current, individually verified analyst price targets, rounded from roughly $68.50. With the latest close near $55.37 , reaching $68 implies upside of about 23% , a substantial move.
Aramark reported fourth-quarter fiscal 2026 revenue of $5.29 billion , up about 5% on a reported basis and up 12% on an organic basis. Adjusted earnings per share (EPS) came in at $0.71 , up roughly 25% on a constant-currency basis but below the consensus estimate of about $0.75.